Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal anti…
Biotechnology
US, New York [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Y-mAbs Therapeutics, Inc. (YMAB) to it's peer group.
Peer Group
RVMD PCVX KRON ZNTL PASG SNDX CCCC GBIO BDTX DAWN ARQT MIRM LRMR MRSN EWTX STRO ICVX ERAS TVTX TCRR BLUE BCEL
Compare Together
Loading...